Medical and Science
New Code of Conduct to take effect on 30 March
Medicines Australia’s new Code of Conduct is now available online ahead of its implementation on 30 March 2020.
Edition 19 of the Code of Conduct has adopted a principles-based approach, streamlining information into clear sections and removing outdated provisions from previous editions, while maintaining the same ethical standards and transparency of reporting.
In the past, Medicines Australia has produced a document which outlines the changes made when releasing a new edition of the Code. Edition 19 of the Code underwent a complete re-write, which makes the production of such a document impossible.
To enhance understanding and application of this Code, Medicines Australia has created the Code of Conduct Resource Tool Kit. This manual is produced as a separate publication. The Toolkit provides insight both into the experiences of the Code of Conduct, Appeals and Monitoring Committees and the deliberations of Medicines Australia and its members when developing amendments to the Code of Conduct.
During her last interview with Health Industry Hub, Ms Deborah Monk, former Director of Ethics and Compliance, Medicines Australia stated “Over the next three to five years, we would like to see the principles-based Code of Conduct securely embedded in our member companies. Additionally, we endeavour to have the number of complaints being raised under the Code remain at a relatively low level demonstrating a good level of compliance amongst companies.”
Medicines Australia recommends the Code of Conduct Bridging Program conducted by the University of Tasmania, to provide detailed information on the application of the Code of Conduct.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
Enhance employer branding and boost thought leadership in the industry to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting your organisation to Australia’s Pharma, MedTech, and Biotech industry professionals. Learn about our unique media solutions.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreNews & Trends - Pharmaceuticals
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More